PulseJournal ClubResearchersJournalsExplore
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
August 28, 2024Journal of Medicinal ChemistryOpen Access

Structure–Activity Relationship of Antibody–Oligonucleotide Conjugates: Evaluating Bioconjugation Strategies for Antibody–siRNA Conjugates for Drug Development

View Full Paper
Ask AI
Bookmark
Share

Authors

MCMichael A. CochranDADanny AriasRBRob S. Burke

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cochran et al. (2024) studied this question.

synapsesocial.com/papers/68e5a818b6db6435875425e8https://doi.org/10.1021/acs.jmedchem.4c00802
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Neutral BackboneModifications Enhance the Pharmacokineticsand Biodistribution of Antibody–Oligonucleotide Conjugateswith High Drug-to-Antibody Ratios2026
  2. 2Supramolecular Bioconjugation Strategy for Antibody-Targeted Delivery of siRNA2024 · 1 citations
  3. 3Molecular Insights into the Bio-oligomer Complexation with siRNA toward Therapeutic Applications2025
  4. 4Staufen dsRNA-binding domain as modules to design bifunctional antibodies for siRNA delivery.2026 · 1 citations
  5. 5Structure–Activity Relationship of Antibody–Oligonucleotide Conjugates: Evaluating Bioconjugation Strategies for Antibody–Phosphorodiamidate Morpholino Oligomer Conjugates for Drug Development2024 · 6 citations